Found 0 matching trials
Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer
PHASE2This phase II trial tests how well cemiplimab works in treating patients wi...
Location
Multiple Locations
Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma
PHASE2This research study involves an investigational product: Ad-RTS-hIL-12 give...
Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy
PHASE2This phase II trial tests how well diclofenac works in treating patients no...
Location
Emory University Hospital Midtown
Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery
PHASE2A non-randomized two-cohort study of neoadjuvant Cemiplimab or neoadjuvant ...
Location
University of Miami Health System
Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features
PHASE2The goal of this clinical trial is to learn about neoadjuvant cemiplimab wi...
Location
Lombardi Comprehensive Cancer Center, Georgetown University
Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)
PHASE2This study is being conducted to find out if treatment with gemcitabine, ci...
Location
Columbia University Irving Medical Center
Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma
PHASE1This phase I trial studies the side effects and best dose of Actimab-A when...
Location
Multiple Locations
Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy
PHASE1This trial studies the side effects of short-term fasting in patients with ...
Status
Active Not Recruiting
Location
Los Angeles General Medical Center
Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer
PHASE3This phase III trial compares the effect of adding cemiplimab to standard t...
Location
University of Alabama at Birmingham Cancer Center
Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before Surgery
PHASE2This phase II trial studies how well cemiplimab works before surgery in tre...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center